These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37826949)

  • 21. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
    Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
    J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colesevelam attenuates cholestatic liver and bile duct injury in
    Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
    Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Epidermal Growth Factor Receptor Ligand Amphiregulin Protects From Cholestatic Liver Injury and Regulates Bile Acids Synthesis.
    Santamaría E; Rodríguez-Ortigosa CM; Uriarte I; Latasa MU; Urtasun R; Alvarez-Sola G; Bárcena-Varela M; Colyn L; Arcelus S; Jiménez M; Deutschmann K; Peleteiro-Vigil A; Gómez-Cambronero J; Milkiewicz M; Milkiewicz P; Sangro B; Keitel V; Monte MJ; Marin JJG; Fernández-Barrena MG; Ávila MA; Berasain C
    Hepatology; 2019 Apr; 69(4):1632-1647. PubMed ID: 30411380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice.
    Chen P; Li D; Chen Y; Sun J; Fu K; Guan L; Zhang H; Jiang Y; Li X; Zeng X; Chen X; Huang M; Bi H
    Br J Pharmacol; 2017 Dec; 174(23):4345-4361. PubMed ID: 28910492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADAM Metalloproteinase Domain 17 Regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice.
    Almishri W; Swain LA; D'Mello C; Le TS; Urbanski SJ; Nguyen HH
    Front Immunol; 2021; 12():779119. PubMed ID: 35095853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
    Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
    Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics research on the hepatoprotective effect of cultured bear bile powder in α-naphthylisothiocyanate-induced cholestatic mice.
    Wu J; Fang S; Li W; Li Y; Li Y; Wang T; Yang L; Liu S; Wang Z; Ma Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1153():122269. PubMed ID: 32739790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-25 ameliorates acute cholestatic liver injury via promoting hepatic bile acid secretion.
    Zhao Z; Liu S; Luo S; Zhou L; Liu J; Qian B; Shi J; Zhou Y; Li J; Jiang T; Lv Z; Yang Z
    Cytokine; 2022 Oct; 158():155979. PubMed ID: 35914403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
    Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
    Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.
    Gallucci GM; Trottier J; Hemme C; Assis DN; Boyer JL; Barbier O; Ghonem NS
    Hepatol Commun; 2021 Dec; 5(12):2035-2051. PubMed ID: 34558841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal obesogenic diet enhances cholestatic liver disease in offspring.
    Thompson MD; Hinrichs H; Faerber A; Tarr PI; Davidson NO
    J Lipid Res; 2022 May; 63(5):100205. PubMed ID: 35341737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease.
    Shi Q; Yuan X; Zeng Y; Wang J; Zhang Y; Xue C; Li L
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sortilin 1 Loss-of-Function Protects Against Cholestatic Liver Injury by Attenuating Hepatic Bile Acid Accumulation in Bile Duct Ligated Mice.
    Li J; Woolbright BL; Zhao W; Wang Y; Matye D; Hagenbuch B; Jaeschke H; Li T
    Toxicol Sci; 2018 Jan; 161(1):34-47. PubMed ID: 28453831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice.
    Feng H; Hu Y; Zhou S; Lu Y
    J Appl Toxicol; 2022 Aug; 42(8):1323-1336. PubMed ID: 35128688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
    Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
    Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear receptors as therapeutic targets in cholestatic liver diseases.
    Zollner G; Trauner M
    Br J Pharmacol; 2009 Jan; 156(1):7-27. PubMed ID: 19133988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human menstrual blood-derived stem cell transplantation suppresses liver injury in DDC-induced chronic cholestasis.
    Yang Y; Chen Y; Zhao Y; Ji F; Zhang L; Tang S; Zhang S; Hu Q; Li Z; Zhang F; Li Q; Li L
    Stem Cell Res Ther; 2022 Feb; 13(1):57. PubMed ID: 35123555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
    Yu D; Cai SY; Mennone A; Vig P; Boyer JL
    Liver Int; 2018 Jun; 38(6):1128-1138. PubMed ID: 29356312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr/Nrf2 and CHOP-DR5-caspase-8 pathway.
    Song G; Weng F; Zou B; Zhao J; Jin J; Yan D; Huang K; Sun X; Liu C; Hu Y; Li Y; Qiu F
    Clin Sci (Lond); 2023 Apr; 137(7):561-577. PubMed ID: 36795945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
    Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.